Target intelligence / Profile preview

Lysosomal acid alpha-glucosidase (GAA)

Target
GAA
Molecular classification
Enzyme, Glycosidase
01

Overview

Lysosomal acid alpha-glucosidase (GAA) is a lysosomal enzyme that catalyzes the hydrolysis of α(1→4)-linked glucose residues from glycogen, producing free glucose within lysosomes. It is essential for normal cellular energy metabolism. Deficiency of GAA leads to Pompe disease, characterized by glycogen accumulation in lysosomes. Recombinant human GAA (rhGAA) is used for enzyme replacement therapy. High-resolution crystal structures are available for rhGAA, providing insights into its function and informing drug design.

Other names
Acid maltaseGAA
02

Mechanism of action

Enzyme replacement therapy (ERT)

03

Biological functions

Glycogen hydrolysisGlucose productionLysosomal functionEnergy metabolism
04

Disease associations

Pompe disease (Glycogen storage disease type II)
05

Safety considerations

Immune responses to ERTVariable tissue uptake of ERT
06

Interacting drugs

Alglucosidase alfa

1 more in the full profile.

07

Biomarkers

Glycogen levelsEnzyme activity

Beyond the preview

Go deeper on Lysosomal acid alpha-glucosidase (GAA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lysosomal acid alpha-glucosidase (GAA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call